Fidelity Investments’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Fidelity Investments’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,092,700	Closed	-$47.2M	–	2829
2015 Q3	$47.2M	Sell	1,092,700 -1,051,299	-49%	-$44.4M	0.01%	1270
2015 Q2	$90.6M	Sell	2,143,999 -1,775,501	-45%	-$74.9M	0.01%	1076
2015 Q1	$152M	Buy	3,919,500 +1,141,644	+41%	+$44M	0.02%	827
2014 Q4	$93.5M	Sell	2,777,856 -214,291	-7%	-$7.57M	0.01%	1038
2014 Q3	$105M	Buy	2,992,147 +237,052	+9%	+$8.13M	0.01%	946
2014 Q2	$90.5M	Sell	2,755,095 -745,566	-21%	-$25.5M	0.01%	1056
2014 Q1	$130M	Buy	3,500,661 +880,882	+34%	+$32.3M	0.02%	837
2013 Q4	$101M	Buy	2,619,779 +163,885	+7%	+$5.17M	0.01%	978
2013 Q3	$67.3M	Sell	2,455,894 -363,621	-13%	-$8.62M	0.01%	1137
2013 Q2	$59.2M	Buy	+2,819,515	New	+$55M	0.01%	1166

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Fidelity Investments's WX Position: Q4 2015 in Review

Fidelity Investments sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 1,092,700 shares — an estimated $47.2M sold.

Fidelity Investments first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $152M in Q1 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Fidelity Investments reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Fidelity Investments sold 1,092,700 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $47.2M.
Fidelity Investments first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
Fidelity Investments's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $152M in Q1 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Fidelity Investments's 13F filing for Q4 2015, filed 12 Feb 2016.